• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何在中低收入国家改善宫颈癌预防?

How Should Cervical Cancer Prevention Be Improved in LMICs?

机构信息

An assistant professor in the Department of Family Medicine at the Uniformed Services University of the Health Sciences (USU) in Bethesda, Maryland.

A professor in the Department of Family Medicine at the University of Michigan Medical School in Ann Arbor, where he serves as director of the Japanese Family Health Program.

出版信息

AMA J Ethics. 2020 Feb 1;22(2):E126-134. doi: 10.1001/amajethics.2020.126.

DOI:10.1001/amajethics.2020.126
PMID:32048583
Abstract

Cervical cancer has become rare in high-income countries but is a leading cause of mortality among women in low- and middle-income countries (LMICs). This inequity is due to economic, social, and cultural factors and should be seen as an epidemiological tragedy. This article examines ethical considerations that should compel policymakers and international donors to prioritize cervical cancer prevention in LMICs.

摘要

宫颈癌在高收入国家已较为罕见,但在中低收入国家(LMICs)仍是女性死亡的主要原因。这种不平等是由经济、社会和文化因素造成的,应被视为一场流行病学悲剧。本文探讨了应促使政策制定者和国际捐助者优先考虑中低收入国家宫颈癌预防工作的伦理考虑因素。

相似文献

1
How Should Cervical Cancer Prevention Be Improved in LMICs?如何在中低收入国家改善宫颈癌预防?
AMA J Ethics. 2020 Feb 1;22(2):E126-134. doi: 10.1001/amajethics.2020.126.
2
Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries?为什么要考虑在中低收入国家进行宫颈癌自我采样筛查?
AMA J Ethics. 2020 Feb 1;22(2):E116-125. doi: 10.1001/amajethics.2020.116.
3
How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control?中低收入国家应如何激励癌症预防与控制中的公平性?
AMA J Ethics. 2020 Feb 1;22(2):E147-155. doi: 10.1001/amajethics.2020.147.
4
The Unique Issues With Brachytherapy in Low- and Middle-Income Countries.低收入和中等收入国家近距离放射治疗的独特问题
Semin Radiat Oncol. 2017 Apr;27(2):136-142. doi: 10.1016/j.semradonc.2016.11.005. Epub 2016 Nov 10.
5
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.建立循证基础以指导最佳实践:低收入和中等收入国家乳腺癌与宫颈癌综述的范围界定研究
PLoS One. 2015 Sep 1;10(9):e0134618. doi: 10.1371/journal.pone.0134618. eCollection 2015.
6
Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries.应对中低收入国家乳腺癌和宫颈癌的新挑战。
Int J Gynaecol Obstet. 2012 Oct;119 Suppl 1:S85-8. doi: 10.1016/j.ijgo.2012.03.024. Epub 2012 Aug 9.
7
Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.低收入和中等收入国家宫颈癌预防服务利用不足:影响因素综述
Pan Afr Med J. 2015 Jul 30;21:231. doi: 10.11604/pamj.2015.21.231.6350. eCollection 2015.
8
The inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?反向公平性假说:它适用于中等收入国家的癌症筛查覆盖情况吗?
J Epidemiol Community Health. 2015 Feb;69(2):149-55. doi: 10.1136/jech-2014-204355. Epub 2014 Oct 13.
9
A systematic review on ethical challenges of 'field' research in low-income and middle-income countries: respect, justice and beneficence for research staff?在低收入和中等收入国家开展“实地”研究的伦理挑战的系统评价:研究人员的尊重、公正和慈善?
BMJ Glob Health. 2021 Jul;6(7). doi: 10.1136/bmjgh-2021-005380.
10
Global justice and health systems research in low- and middle-income countries.全球正义与低收入和中等收入国家的卫生系统研究。
J Law Med Ethics. 2015 Spring;43(1):143-61. doi: 10.1111/jlme.12202.

引用本文的文献

1
Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.低收入和中低收入国家的宫颈癌趋势、人乳头瘤病毒疫苗接种情况及筛查:最新综述
Ther Adv Vaccines Immunother. 2025 Jul 24;13:25151355251356646. doi: 10.1177/25151355251356646. eCollection 2025.
2
Applying FRAME-IS to Characterize Provider-led Adaptations to a Cervical Cancer Prevention Intervention in Kenya.应用FRAME-IS来描述肯尼亚提供者主导的宫颈癌预防干预措施的适应性。
Res Sq. 2025 Jul 15:rs.3.rs-6933921. doi: 10.21203/rs.3.rs-6933921/v1.
3
Comparative effectiveness and immunogenicity of single-dose and multi-dose human papillomavirus vaccination: a systematic review.
单剂量和多剂量人乳头瘤病毒疫苗的比较效果与免疫原性:一项系统评价
BMC Public Health. 2025 Jul 3;25(1):2330. doi: 10.1186/s12889-025-23496-4.
4
Sexual and Reproductive Health and Rights and Global Development.性与生殖健康及权利与全球发展
Stud Fam Plann. 2025 Jun;56(2):232-242. doi: 10.1111/sifp.70016. Epub 2025 May 22.
5
Addressing Global Disparities in Cervical Cancer Burden: A Narrative Review of Emerging Strategies.应对宫颈癌负担的全球差异:新兴策略的叙述性综述
Curr HIV/AIDS Rep. 2025 Feb 21;22(1):18. doi: 10.1007/s11904-025-00727-2.
6
Factors explaining men's intentions to support their partner's participation in cervical cancer screening.解释男性支持其伴侣参与宫颈癌筛查意愿的因素。
BMC Womens Health. 2022 Nov 11;22(1):443. doi: 10.1186/s12905-022-02019-y.
7
Cervical cancer screening in low- and middle-income countries: A systematic review of economic evaluation studies.中低收入国家的宫颈癌筛查:经济评估研究的系统评价。
Clinics (Sao Paulo). 2022 Jul 26;77:100080. doi: 10.1016/j.clinsp.2022.100080. eCollection 2022.
8
Cervical cancer screening coverage and its related knowledge in southern Malawi.马拉维南部的宫颈癌筛查覆盖率及其相关知识。
BMC Public Health. 2022 Feb 14;22(1):295. doi: 10.1186/s12889-022-12547-9.
9
Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.行动呼吁:加速在中低收入国家普及 HPV 疫苗接种的行动框架。
Int J Gynaecol Obstet. 2021 Jan;152(1):32-39. doi: 10.1002/ijgo.13482.